检索结果-南通市图书馆

Journal of Natural Gas Chemistry 2008年第2期17卷 113-119页

作者： Jangam Ashok Gangadhara Raju padigapati shiva reddy Machiraju Subrahmanyam Akula Venugopal Catalysis and Physical Chemistry Division Indian Institute of Chemical TechnologyTarnakaHyderabadIndia-500 607

This article reports the production of COx free hydrogen and carbon nanofibers by the catalytic decomposition of methane over Ni-Al2O3-SiO2 catalysts. The influence of reaction temperature, pretreatment temperature, and effect of reductive pretreatment on the decomposition of methane activity is investigated. The physico-chemical characteristics of fresh and deactivated samples were characterized using BET-SA, XRD, TPR, SEM/TEM, CHNS analyses and correlated with the methane decomposition results obtained. The Ni-Al-Si （4 ： 0.5 ： 1.5） catalyst reduced with hydrazine hydrate produced better H2 yields of ca. 1815 mol H2/mol Ni than the catalyst reduced with 5% H2/N2.

关键词： in situ reduction Ni-Al2O3-SiO2 catalyst methane decomposition hydrogen production carbon nanofibers

Experimental Evaluation of a Multistage Reciprocating Evaporative Cooler Performance for Varied Climatic Conditions

在线全文

学校读者我要写书评

暂无评论

Journal of Thermal Science 2023年第4期32卷 1523-1535页

作者： Sampath SURANJAN SALINS S.V.KOTA reddy shiva KUMAR School of Engineering and IT Manipal Academy of Higher EducationDubai CampusDubaiPO 345050UAE Mechanical Engineering Department VIT-AP UniversityAmaravatiAndra Pradesh52223India Department of Mechanical and Manufacturing Engineering Manipal Institute of TechnologyManipal Academy of Higher EducationManipal576104India

Current system focuses on design&construction of a multistage reciprocating evaporative cooling test *** packings that are used will undergo the reciprocating action,powered by the cam follower mechanism maintained at an actual rotation *** dry bulb temperature&humidity values are varied to replicate the varying climatic conditions,and the output parameters such as cooling load,evaporation rate(ER),humidification efficiency(HE),coefficient of performance(COP)are *** results showed that as inlet humidity raises,the performance of system *** the rise in the camshaft speed or packing velocity,there is an upsurge in the performance until a cam speed of 10 r/min or packing velocity of 0.083 m/s and with further increases in the value,overall performance *** system gave a maximum COP,ER,and HE equal to 3.80,73.87%,and 0.53 g/kg respectively.A rise in the inlet air temperature yielded a maximum change in dry bulb temperature of 8.2℃.Overall,results indicated that evaporative cooling is more effective in arid climates than the cold and humid *** quality test is performed to measure CO_(2),Total Volatile Organic Compound(TVOC),and Formaldehyde(HCHO),and it is found that humidified air entering the defined space is of excellent quality.

关键词： multistage humidifier evaporative cooling reciprocating packing humidification efficiency

Solvent-free aerobic oxidation of ethylbenzene over supported Ni catalysts using molecular oxygen at atmospheric pressure

在线全文

学校读者我要写书评

暂无评论

Journal of Natural Gas Chemistry 2008年第3期17卷 293-297页

作者： G.Raju P.shiva reddy J.Ashok B.Mahipal reddy A.Venugopal Catalysis & Physical Chemistry Division Indian Institute of Chemical Technology

We investigated the aerobic oxidation of ethylbenzene in the absence of solvent or any additive carried out over Ni on different types of supports namely SiO2, hydroxyapatite, SBA-15, and USY Zeolites. The oxidation of ethylbenzene activities was measured in a round bottom flask immersed in oil bath at known reaction temperature. The physicochemical characteristics of the catalysts were examined by BET surface area, XRD, FT-IR and the oxidation activities were correlated with the acidities of the catalysts obtained by TPD of NH3. It was observed that both hydroxyapatite and USY （13% Na2O） supported Ni catalysts displayed higher ethylbenzene conversion and 80% selectivity towards acetophenone.

关键词： nickel SBA-15 zeolites hydroxyapatite ethylbenzene oxidation TPD of NH3

Castleman disease presenting with jaundice: A case report and review of literature

在线全文

学校读者我要写书评

暂无评论

World Journal of Clinical Cases 2019年第3期7卷 373-381页

作者： Bo Zhai Hai-Yang Ren Wei-Dong Li shiva reddy Shu-Jun Zhang Xue-Ying Sun Department of General Surgery The Fourth Affiliated Hospital of Harbin Medical University Hepatosplenic Surgery Center The First Affiliated Hospital of Harbin Medical University Department of Molecular Medicine and Pathology Faculty of Medical and Health Sciences The University of Auckland Department of Pathology The Fourth Affiliated Hospital of Harbin Medical University

BACKGROUND Castleman disease(CD) is a rare lymphoproliferative disorder that presents with various symptoms. CD accompanied with jaundice is uncommon since there are only 11 cases reported in the *** SUMMARY Here we report a 62-year-old woman who was admitted to the hospital with signs and symptoms of intermittent jaundice. Biochemical tests showed higher serum levels of total and direct bilirubin, and normal serum levels of tumor markers and interleukin-6. Contrast-enhanced computed tomography detected a6 cm × 4 cm × 2.5 cm mass between the hepatoduodenal ligament and the inferior vena cava. The mass was successfully excised and the patient had a complete resolution of symptoms. A diagnosis of idiopathic unicentric CD was made based upon histological examination, which demonstrated the pathological features of CD of mixed type, including hyperplasia of follicular lymphoids with abundant plasma cells, degenerative germinal centers, interfollicular vascularity and hyaline degeneration. The diagnosis was corroborated by immunohistochemical analysis which detected multiple *** This is the first study that describes the clinicopathological features of CD presenting with jaundice, which may deepen and extend our understanding of this disease.

关键词： Castleman disease Jaundice Case report Clinicopathology Immunohistochemistry

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes:A systematic review and metaanalysis

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2023年第21期29卷 3362-3378页

作者： Gowthami Sai Kogilathota Jagirdhar Rakhtan K Qasba Harsha Pattnaik Kaanthi Rama Akshat Banga shiva Teja reddy Anna Carolina Flumignan Bucharles Rahul Kashyap Praveen reddy Elmati Vikas Bansal Yatinder Bains Theodore DaCosta Salim Surani Department of Medicine Saint Michaels Medical CenterNewarkNJ 07102United States Department of Medicine Green Life Medical College and HospitalDhaka 1205Bangladesh Department of Medicine Lady Hardinge Medical CollegeNew Delhi 110001India Department of Medicine Gandhi Medical CollegeTelangana 500003India Department of Medicine Sawai Man Singh Medical CollegeJaipur 302004RajistanIndia Department of Medicine Universidade PositivoCuritiba 81290-000PRBrazil Research WellSpan HealthYorkPA 17403United States Department of Interventional Pain Medicine University of LouisvilleLouisvilleKY 40292United States Department of Internal Medicine Mayo ClinicRochesterMN 55902United States Department of Gastroenterology Saint Michaels Medical CenterNewarkNJ 07102United States Department of Medicine Texas A&M UniversityCollege StationTX 77843United States

BACKGROUND Non-alcoholic fatty liver disease(NAFLD)and metabolic-associated fatty liver disease(MAFLD)are on the rise like any other liver disease,and tend to affect 25%of the United States *** impact of NAFLD and MAFLD on patients with coronavirus disease 2019(COVID-19)remains *** To identify the association of NAFLD and MAFLD with mortality,hospitalization,hospital length of stay,and supplemental oxygen utilization in COVID-19 *** A systematic review of literature on Cochrane,Embase,PubMed,ScienceDirect,and Web of Science databases was conducted from January 2019 to July *** that evaluated NAFLD/MAFLD using laboratory methods,noninvasive imaging,or liver biopsy were *** study protocol was registered in PROSPERO(ID CRD42022313259)and PRISMA guidelines were *** National Institutes of Health quality assessment tool was used to assess the quality of the *** analysis was conducted using software Rev Man version *** stability of the results was assessed using sensitivity *** Thirty-two studies with 43388 patients were included in the meta-analysis of whom 8538(20%)patients were observed to have *** were 42254 patients from 28 studies included in the mortality analysis.A total of 2008 patients died from COVID-19;837(10.52%)in the NAFLD group and 1171(3.41%)in the non-NAFLD *** odds ratio(OR)was 1.38 for mortality with a 95%confidence interval(95%CI)=0.97-1.95 and P=0.07.A total of 5043 patients from eight studies were included in the hospital length of stay *** were 1318 patients in the NAFLD group and 3725 patients in the non-NAFLD group.A qualitative synthesis showed that the mean difference in hospital length of stay was about 2 d between the NAFLD and non-NAFLD groups with a 95%CI=0.71-3.27 and P=*** hospitalization rates,the OR was 3.25 with a 95%CI of 1.73-6.10 and P=*** supplemental oxygen utilization,the OR was 2.04 with a 95%CI of 1.17-3.5

关键词： Non-alcoholic fatty liver Fatty liver Coronavirus COVID-19 Metabolic-associated fatty liver

Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC–MS/MS

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Pharmaceutical Analysis 2017年第3期7卷 196-202页

作者： shiva Kumar Gudlawar Nageswara Rao Pilli Sridhar Siddiraju Jaya Dwivedi Department of Chemistry Banasthali VidyapeethJaipur 304022India Wellquest Clinical Research Laboratories RamanthapurHyderabad 500013India Department of Pharmaceutical Chemistry Malla Reddy College of PharmacyMaisammagudaSecunderabad 5000100India

An analytical method based on ultra-performance liquid chromatography with positive ion electrospray ionization(ESI) coupled with tandem mass spectrometry(UPLC–MS/MS) was developed and validated for the determination of therapeutic peptide desmopressin in human plasma. A desmopressin stable labeled isotope(desmopressin d_8) was used as an internal standard. Analyte and the internal standard were extracted from200 μL of human plasma via solid-phase extraction technique using Oasis WCX cartridges. The chromatographic separation was achieved on an Aquity UPLC HSS T3 column by using a gradient mixture of methanol and 1 m M ammonium formate buffer as the mobile phase. The calibration curve obtained was linear(r^2≥0.99)over the concentration range of 1.01–200 pg/m L. Method validation was performed as per FDA guidelines and the results met the acceptance criteria. The results of the intra-and inter-day precision and accuracy studies were well within the acceptable limits. The proposed method was successfully applied to pharmacokinetic studies in humans.

关键词： Desmopressin Solid-phase extraction (SPE) Ultra performance liquid chromatography–tandem mass spectrometry Method validation Pharmacokinetics

Safety and Efficacy of a Novel Everolimus-Eluting Stent System in “Real-World” Patients with Coronary Artery Disease: A Report of Preliminary Outcomes

在线全文

学校读者我要写书评

暂无评论

World Journal of Cardiovascular Diseases 2016年第12期6卷 458-467页

作者： Sridhar Kasturi Srinivas Polasa Shailender Singh Vijay Kumar reddy Kondal Rao Ganesh Mathan shiva Kumar Bandimida Manikandhar Pendyala Chandrashekar Challa Sunshine Heart Institute Secunderabad India Chalmeda Anandrao Institute of Medical Sciences Karimnagar India

Introduction: Tetrilimus (Sahajanand Medical Technologies Pvt. Ltd., Surat, India) is a recently-introduced biodegradable-polymer coated everolimus-eluting cobalt-chromium coronary stent system with an ultra-thin strut thickness. We aimed to evaluate the clinical outcomes with Tetrilimus coronary stents in “real-world” patients with coronary artery disease. Methods: In this retrospective, single-arm, open-label, multi-center registry, all consecutive patients who received Tetrilimus stents between July-2015 and April-2016 at two tertiary-care centers in India were analyzed. Primary endpoint was 30-day incidence of major adverse cardiac events (MACE), defined as a composite of cardiac death, myocardial infarction, target lesion revascularization, and target vessel revascularization. The Academic Research Consortium (ARC)-defined stent thrombosis was assessed as additional safety endpoint. Results: During the study period, 280 Tetrilimus stents (1.4 ± 0.5 stent/patient) were implanted to treat 252 coronary lesions (1.1 ± 0.3 stent/lesion) in 208 patients (age: 57.5 ± 11.9 years). Of study population, 65.9% were males, 46.6% were hypertensives, 25% were diabetics, 36.5% were alcoholics, 29.3% were smokers, 13.9% were tobacco chewers, 5.3% had previous revascularization, and 45.2% displayed multi-vessel disease. Of treated lesions, 67.5% were complex and 18.7% had total occlusion. Average length and diameter of implanted stents were 25.5 ± 8.8 mm and 2.9 ± 0.3 mm respectively. Subsequently, 30-day MACE were reported in 2 (0.96%) patients;both cases owing to in-hospital cardiac deaths. Events of stent thrombosis or noncardiac death were not reported in any patient. Conclusion: Low MACE rates and absence of stent thrombosis at early 30-day follow-up indicates that Tetrilimus everolimus-eluting stents may have encouraging safety and efficacy in unselected “real-world” patients with coronary artery disease.

关键词： Biodegradable Polymer Percutaneous Coronary Intervention Everolimus-Eluting